Implication of Transforming Growth Factor–β1 in Chagas Disease Myocardiopathy (original) (raw)

The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease

CRISTINA MAN

Clinical Cardiology, 2015

View PDFchevron_right

Implication of Transforming Growth Factor��1 in Chagas Disease Myocardiopathy

Mariana Waghabi

J Infec Dis, 2002

View PDFchevron_right

Novel Therapeutic Strategies for Chagas` Disease

Solange Lisboa de Castro

Drug Development - A Case Study Based Insight into Modern Strategies, 2011

View PDFchevron_right

Immunopathology of cardiomyopathy in the experimental Chagas disease

RICARDO ANTONIO ANDRADE SANTOS

Memórias do Instituto Oswaldo Cruz, 1999

View PDFchevron_right

Clinical and nutritional profile of individuals with chagas disease

Juliana Geraix

Brazilian Journal of Infectious Diseases, 2007

View PDFchevron_right

P1600High sensitive cardiac troponin elevations in patients with Chagas disease without evidence of structural heart affection

DANIEL CHIRINO

European Heart Journal, 2018

View PDFchevron_right

Congenital Chagas disease: alert of research negligence

Nadjar Nitz

Revista da Sociedade Brasileira de Medicina Tropical, 2019

View PDFchevron_right

Echocardiographic and Clinical Predictors of Mortality in Chronic Chagas' Disease

Hector Gonzalez

Echocardiography, 1998

View PDFchevron_right

Case Report: Malignant Ventricular Arrhythmias Mimicking Acute Coronary Syndrome in Chagas Disease

SERGIO SALLES Xavier

The American Journal of Tropical Medicine and Hygiene, 2020

View PDFchevron_right

A new patient registry for Chagas disease

Sergio Sosa-estani

PLOS Neglected Tropical Diseases, 2020

View PDFchevron_right

Experimental Chronic Chagas' Disease Myocarditis is an Autoimmune Disease Preventable by Induction of Immunological Tolerance to Myocardial Antigens

RICARDO ANTONIO ANDRADE SANTOS

Journal of Autoimmunity, 2002

View PDFchevron_right

Left Ventricular Scar and Prognosis in Chronic Chagas Cardiomyopathy

André Schmidt

Journal of the American College of Cardiology, 2018

View PDFchevron_right

BAT1, a Putative Anti‐Inflammatory Gene, Is Associated with Chronic Chagas Cardiomyopathy

Anna Carla Goldberg

The Journal of Infectious Diseases, 2006

View PDFchevron_right

Evaluation and Treatment of Chagas Disease in the United States

Jose Marin-neto

JAMA, 2007

View PDFchevron_right

Early PCR Detection of Chagas Disease Reactivation in Heart-Transplanted Patients

Lucas Junqueira

The Journal of Heart and Lung Transplantation, 2017

View PDFchevron_right

P6538The journey of patients with Chagas cardiomyopathy during episodes of descompensated heart failure

Silvia Lage

European Heart Journal, 2018

View PDFchevron_right

Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice

Roberto Saraiva

European Journal of Clinical Microbiology & Infectious Diseases, 2012

View PDFchevron_right

Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects

SERGIO SALLES Xavier

Revista da Sociedade Brasileira de Medicina Tropical, 2021

View PDFchevron_right

Update on Chagas disease in Venezuela: a review

Nestor Anez

Memórias do Instituto Oswaldo Cruz, 2004

View PDFchevron_right

Case 4/2019 - 26-Year-Old Man with Congenital Chagas Disease and Heart Transplantation

Henrique Trombini Pinesi

Arquivos Brasileiros de Cardiologia, 2019

View PDFchevron_right

Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy

Luiza Guilherme

Brazilian Journal of Medical and Biological Research, 1998

View PDFchevron_right

Chagas' disease diagnosis: evaluation of several tests in blood bank screening

Amadeo Sáez-Alquezar

Transfusion, 1993

View PDFchevron_right

Modulation of Chagasic Cardiomyopathy by Interleukin-4

Moema Cortizo Bellintani

The American Journal of Pathology, 2001

View PDFchevron_right

Heart Rate Turbulence in Chagas Disease

Marcos Sousa

Pacing and Clinical Electrophysiology, 2003

View PDFchevron_right

Chronic Chagas Cardiomyopathy in the Brazilian Amazon region: clinical characteristics and regional distinctiveness

Victor Irungu

Frontiers in Public Health, 2023

View PDFchevron_right

Chagasic Cardiomyopathy

Fernando Rosas

Cardiomyopathies - From Basic Research to Clinical Management, 2012

View PDFchevron_right

Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease

Jean-jacques Feige, Mariana Waghabi

PLoS Neglected Tropical Diseases, 2012

View PDFchevron_right

Towards improving early diagnosis of congenital Chagas disease in an endemic setting

Victoria Rendell

Clinical Infectious Diseases, 2017

View PDFchevron_right

Chagas' Disease: Serodiagnosis with Purified Gp25 Antigen

L. Mendonça-previato

The American Journal of Tropical Medicine and Hygiene

View PDFchevron_right

Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study

Jose Antonio Pioquinto Ramirez

The American Journal of Tropical Medicine and Hygiene, 1999

View PDFchevron_right

Chagas Disease and Heart Failure: An Expanding Issue Worldwide

Sergio V. Perrone

European Cardiology Review

View PDFchevron_right

Predictive value of transforming growth factor- 1in Chagas disease: towards a biomarker surrogate of clinical outcome

F. Madeira, Roberto Saraiva, Sérgio Xavier

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013

View PDFchevron_right

Pathogenesis of Chronic Chagas Heart Disease

Edecio Cunha-Neto

Circulation, 2007

View PDFchevron_right

Chagas disease / COVID-19 comorbidity. An advantage to chagasic patients?

Nestor Anez

Revista biomédica, 2022

View PDFchevron_right

Baroreflex sensitivity and its association with arrhythmic events in Chagas disease

Mauricio I Scanavacca

Arquivos Brasileiros de Cardiologia, 2014

View PDFchevron_right